Abstract:Mouse embryonic stem cells (ESCs) are derived from the inner cell mass of mouse blastocysts. Mouse ESCs are pluripotent and contribute widely to the formation of the three embryonic germ layers in chimeric mice but not to that of the extra-embryonic trophectoderm. A small population of transient cells (less than 1%) has been identified occasionally in the culture of mouse ESCs, which has been shown to exhibit a gene expression profile similar to that of cells in 2-cell stage embryos (2C-like cells). 2C-like cells were found to be generated spontaneously from mouse ESCs and induced pluripotent stem cells (iPSCs) when they were cultured in the serum-supplemented with leukemia inhibitory factor (LIF) on feeder cells in vitro. 2C-like cells have been considered to be totipotent. There is evidence suggesting that 2C-like cells can effectively generate both embryonic and extra-embryonic tissues, and therefore, 2C-like cells can be potentially used as a model for in vitro totipotent stem cell research. However, only a small population of ESCs could transit to 2C-like state in the serum-containing culture medium. There are several 2C specific genes that express when ESCs enter 2C-like state, such as Zscan4, Mervl, Dux, Nelfa, Tdpoz1/2/4 and Tcstv1/3. Notably, 2C-like cells exhibit highly relaxed chromatin architecture, which is similar to that observed in 2-cell stage embryos. Genome-wide demethylation occurs upon transition of mouse ESCs into 2C-like state, including gene bodies, promoters, and repeat elements. The dynamics of the reprogramming process from ESCs to 2C-like cells are still unclear, which have certainly uncovered an intricate regulatory mechanism mediated by specific genes, proteins, as well as some metabolites and non-coding RNAs. Additionally, one of the important features of totipotency is that a single cell can form an entire organism. Therefore, totipotent stem cells form a valuable tool to study the early developmental processes in vitro and prove to be beneficial for regenerative medicine applications. For instance, the embryonic stem cells have been used to generate embryo-like structures. The artificial embryo-like structures not only facilitate the studies on the key events in early embryonic development, but also serve as a model for investigating the early developmental defects occurring in humans. Several previous studies revealed that ESCs at different totipotent states can arise in in vitro cultures, and they focused on identifying culture conditions that induce 2C-like states. For example, knockout serum replacement (KOSR) media promotes the induction of 2C-like cells from ESCs in in vitro culture, as indicated by the increased levels of ZSCAN4-positive cells. Additionally, the suppression of glycolysis mediated by 2-deoxy-d-glucose (2-DG) in serum plus LIF condition induces the 2C transcriptional programming in ESCs. Interestingly, the most recent research indicates that the spliceosomal repression in mouse ESCs drives the pluripotent-to-totipotent state transition. Using the splicing inhibitor pladienolide B, they achieved stable in vitro culture of totipotent ESCs comparable at the molecular levels with 2- and 4-cell blastomeres. In our recent study, we also demonstrated that retinoic acid induces NELFA-mediated 2C-like state of mouse embryonic stem cells, which is associated with epigenetic modifications and metabolic processes in chemically defined media. Here, we review the discovery, molecular regulatory mechanism, chromatin characteristics, activation strategies, and the relationship of 2C-like cells with somatic reprogramming.

Comparative Analyses of Single-Cell Transcriptomic Profiles between In Vitro Totipotent Blastomere-like Cells and In Vivo Early Mouse Embryonic Cells

Comparative Dissection of Transcriptional Landscapes of Human Ipsc-Nk Differentiation and NK Cell Development

Mouse totipotent stem cells captured and maintained through spliceosomal repression

Rolling back human pluripotent stem cells to an eight-cell embryo-like stage

Rolling back of human pluripotent stem cells to an 8-cell embryo-like stage

Derivation of totipotent-like stem cells with blastocyst-like structure forming potential

Remodeling of H3K9me3 During the Pluripotent to Totipotent-Like State Transition

Single-cell analysis of embryoids reveals lineage diversification roadmaps of early human development

Epigenetic reprogramming in the transition from pluripotency to totipotency

Single cell expression analysis of primate-specific retroviruses-derived HPAT lincRNAs in viable human blastocysts identifies embryonic cells co-expressing genetic markers of multiple lineages

Review on 2C-Like State of Mouse Embryonic Stem Cells

In Vitro Generation of Mouse Morula-Like Cells.

Single-cell Multi-Omics Sequencing of Mouse Early Embryos and Embryonic Stem Cells

Induction of mouse totipotent stem cells by a defined chemical cocktail

Efficient Reprogramming of Mouse Embryonic Stem Cells into Trophoblast Stem-like Cells via Lats Kinase Inhibition

Chromatin structure in totipotent mouse early preimplantation embryos

Lineage regulators TFAP2C and NR5A2 function as bipotency activators in totipotent embryos

Hallmarks of Totipotent and Pluripotent Stem Cell States.

Dissecting Embryonic and Extraembryonic Lineage Crosstalk with Stem Cell Co-Culture.

Linking Incomplete Reprogramming to the Improved Pluripotency of Murine Embryonal Carcinoma Cell-Derived Pluripotent Stem Cells

Differential Transcriptomes and Methylomes of Trophoblast Stem Cells From Naturally-Fertilized and Somatic Cell Nuclear-Transferred Embryos